New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)

We are thrilled to expand Wholeview's services with the NYS OASAS Problem Gambling designation, which enables us to address the growing need for specialized care for people struggling with problematic gambling and gambling disorders," said Dr. Sarah Church, CEO and Founder of Wholeview Read More

At Wholeview Direct, our mission is to make high-quality addiction treatment accessible to everyone, no matter where they are.”— Carly Moskowitz, LMHC Read More

At Wholeview, our medical providers use pharmacogenetic testing to help personalize medication plans for patients with mental health conditions. This process begins with a simple cheek swab collected at home, which is then analyzed in a lab to identify genetic variations that affect how patients metabolize and respond to medications. The resulting report categorizes medications into groups based on their likely effectiveness and risk of side effects. Pharmacogenetic testing can speed up the process of finding the right psychiatric medication, which is especially valuable for patients with both substance use and mental health disorders. By reducing the trial-and-error period, patients may experience quicker symptom stabilization and improved adherence to treatment. However, genetic testing is used as a supplementary tool alongside thorough clinical evaluations and is not a standalone solution. At Wholeview, we integrate this testing into a broader care approach, including therapy and behavioral interventions, and ensure patients are fully informed about its benefits and limitations before proceeding. Read More